VALN

Valneva
VALN

Overview Fund Trends Analyst Outlook Journalist POV
10.04 USD
--0.19
1.86%
At close Updated Oct 17, 4:00 PM EDT
Pre-market
After hours
9.81
--0.23
2.29%
1 day
-1.86%
5 days
-5.01%
1 month
0.7%
3 months
54.46%
6 months
47.86%
Year to date
112.71%
1 year
78.65%
5 years
-64.59%
10 years
-64.59%
 

About: Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Employees: 713

Healthcare Biotechnology
0
Funds holding %
of 7,496 funds
Explore Fund Trends
0
Analysts bullish %
of 2 analysts
See Analyst Outlook
0
Positive news %
of 9 articles
Check Journalist POV
Price charts implemented using Lightweight Charts™